MENU
ABOUT US
MAKE A DONATION
Login
SEARCH
CLOSE
Help Center
subscribe
newsletter
Newsstands
Epoch Shop
Digital Deals
Gift
Editor’s Picks
SPECIAL SERIES
Special Coverage
LATEST ARTICLES
US
US News
US Features
Politics
Crime and Incidents
New York
San Francisco
Los Angeles
Opinion
Thinking About China
Viewpoints
Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
The Reader’s Turn
America Essay Contest
China
US-China Relations
Chinese Regime
Business & Economy
Chinese Culture
China Human Rights
Social Issues
Organ Harvesting in China
World
Africa
Americas
Asia & Pacific
Canada
Europe
UK
Australia
International
Middle East
Business & Economy
Companies
Economy
Markets
Real Estate
ARTS & CULTURE
Fine Arts & Craftsmanship
Performing Arts
Books
Traditional Culture
Shen Yun Special Coverage
Film & TV
Science
News
Space
Environment
Tech
Tech News
Tech Products & Reviews
Social Media
Sports
Video
American Thought Leaders
China Insider
Crossroads
Bright
Lifestyle
Inspired
Family & Education
Personal Finance
American Essence
Entertainment
Film & TV
Entertainment News
Health
News
Aging
Fitness & Nutrition
Wellness
Traditional Wisdom
Mindset
Search Text
SEARCH
EpochTV
US
Politics
China
World
Opinion
Business
Markets
Science
Bright
Health
Arts
Premium
Games
Sports
Livestream
More
Novartis
Novartis to Seek FDA Emergency Use Approval for New COVID-19 Therapy
Novartis said on Jan. 10 that positive data from a clinical trial of COVID-19 therapeutic drug ensovibep has prompted the firm to exercise an option to in-licence the antiviral from ...
January 10, 2022
BY
Tom Ozimek
Novartis Says US Court Upholds Gilenya Patent
ZURICH—Novartis AG said on Tuesday a U.S. court of appeals upheld the validity of a dosage regimen patent ...
January 5, 2022
BY
Reuters
Novartis Options BeiGene Anti-Cancer Therapy in $1 Billion Deal
ZURICH—Novartis has signed an option, collaboration, and license agreement with BeiGene Ltd for anti-cancer therapy ociperlimab (BGB-A1217) to ...
December 21, 2021
BY
Reuters
Roche Shareholders Approve Deal to Buy Novartis’s $20.7 Billion Stake
ZURICH—Roche shareholders voted overwhelmingly on Friday to support the $20.7 billion deal to buy Novartis's nearly one third ...
November 27, 2021
BY
Reuters
Drugmakers Announce Trial of Jakafi for COVID-19 Patients on Ventilators
Two drugmakers plan on testing a drug that blocks enzymes in COVID-19 patients on ventilators in the United States. ...
May 6, 2020
BY
Zachary Stieber
Novartis Gains Permission From US to Test Hydroxychloroquine Against COVID-19
Swiss drugmaker Novartis gained permission from the U.S. Food and Drug Administration to test hydroxychloroquine, a malaria drug ...
April 20, 2020
BY
Zachary Stieber
Novartis Korea Executives Charged With Bribing Doctors
Prosecutors have indicted a former chief executive of the South Korean unit of Novartis and five other former ...
August 13, 2016
BY
The Associated Press
New Drug Could Reduce Cardiovascular Deaths (Video)
The new drug from Novartis could reduce cardiovascular deaths by 20 percent compared to other similar drugs.
August 30, 2014
BY
Epoch Video
TOP NEWS
Health: Young Girls Are Over-Prescribed Birth Control Pills
NEW
By
Jennifer Margulis
Indian Spokesperson: China Building Second Bridge in Disputed Border Area
NEW
By
Aldgra Fredly
Boeing’s Starliner Capsule Docks With Space Station in Uncrewed Flight Test
2hr
By
Reuters
NY State Supreme Court Reinstates Ban on Police Choke Holds During Arrests
3hr
By
Caden Pearson
Florida Court Overturns Ruling on DeSantis Redistricting Map
5hr
By
Caden Pearson
Australians Vote in Hotly Contested Federal Election
5hr
By
Aldgra Fredly
CDC Advises Doctors to Be on Alert for Monkeypox as WHO Confirms Outbreaks in 11 Countries
5hr
By
Mimi Nguyen Ly
Feds Halt Sales of Homemade Guns Before August Rule Is Implemented
6hr
By
Beth Brelje
Incumbent Oregon District Attorneys Fend Off Well-Funded Progressive Challengers
7hr
By
Cara Ding
Biden Appoints John Kirby as NSC Coordinator for Strategic Communications at White House
7hr
By
Caden Pearson